CJC-1295 (no DAC) vs GHK-Cu
Both CJC-1295 (no DAC) and GHK-Cu are used for anti-aging. Here's how their evidence, dosing, and regulatory status actually compare.
CJC-1295 (no DAC)
Evidence BModified Growth Hormone Releasing Factor 1-29
A growth hormone releasing hormone (GHRH) analog most commonly stacked with Ipamorelin to stimulate natural GH pulsatile release without disrupting the hypothalamic axis.
View full CJC-1295 (no DAC) profile →GHK-Cu
Evidence B+Copper Peptide GHK-Cu
A naturally occurring copper-binding tripeptide that modulates 4,000+ human genes. The most studied peptide for skin rejuvenation with both preclinical and clinical topical evidence.
View full GHK-Cu profile →Side-by-Side
| Attribute | CJC-1295 (no DAC) | GHK-Cu |
|---|---|---|
| Evidence Grade | B | B+ |
| FDA Status | Not FDA-approved — Category 1 (compounding allowed) | Not FDA-approved — available as cosmetic ingredient and research compound |
| Typical Dose | 100–300 mcg before bed (subcutaneous) | 1–2 mg daily SC or topical (5 days on / 2 off) |
| Clinics Indexed | 156 | 145 |
| Categories | growth-hormone, anti-aging, recovery | anti-aging, skin, hair |
Key reported benefits — CJC-1295 (no DAC)
- ✓Growth hormone release
- ✓Fat loss
- ✓Improved sleep
- ✓Muscle recovery
Key reported benefits — GHK-Cu
- ✓Collagen synthesis
- ✓Wrinkle reduction
- ✓Hair growth
- ✓Wound healing
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.